C. Dohno et al. / Bioorg. Med. Chem. 17 (2009) 2536–2543
2541
solution and extracted with CHCl3. The organic phase was washed
with brine, dried over anhydrous MgSO4, filtered, and concentrated
in vacuo. The crude product was purified by column chromatogra-
phy on silica gel (ethyl acetate/n-hexane = 1:1) to give 8 (1.44 g,
3.85 mmol, 61% 2 steps from 6) as a pale yellow solid: 1H NMR
(400 MHz, CDCl3) d = 1.42 (s, 9H), 1.59 (m, 2H), 1.74 (m, 2H),
2.75 (s, 3H), 3.16 (m, 2H), 4.22 (t, 2H, J = 6.6 Hz), 4.55 (br, 1H),
7.26 (d, 1H, J = 8.3 Hz), 7.72 (br, 1H), 7.99 (d, 1H, J = 8.3 Hz), 8.11
(d, 1H, J = 8.8 Hz), 8.25 (d, 1H, J = 8.8 Hz); 13C NMR (150 MHz,
CDCl3) d = 25.44, 25.98, 26.41, 28.26, 39.96, 65.25, 79.00, 112.49,
117.79, 121.14, 136.23, 138.81, 153.11, 153.31, 154.53, 155.85,
163.00; ESI-MS, m/e 397 ([M+Na]+); HRMS (FAB): calcd for
C19H27O4N4 ([M+H]+) 375.2032, found 375.2042.
over anhydrous MgSO4. The solvent was evaporated in vacuo and
the crude residue was purified by column chromatography on sil-
ica gel (CHCl3/methanol = 25:1) to give 16 (1.30 g, 4.34 mmol, 25%)
as a pale-yellow oil: 1H NMR (400 MHz, DMSO) d 0.98 (s, 9H), 266
(t, 2H, J = 6.08 Hz), 3.58 (t, 2H, J = 4.88 Hz), 7.43 (m, 6H), 7.61 (m,
4H); 13C NMR (100 MHz, CDCl3) d 18.9, 26.5, 43.9, 65.8, 127.3,
129.3, 133.3, 135.2; HRMS (ESI) calcd for C18H27NOSi [(M+H)+]
300.1783, found 300.1779.
4.1.5. N,N0-Bis[2-(tert-butyldiphenylsilyloxy)ethyl]-4,40-
aminomethylazobenzene (17)
To a solution of 16 (398 mg, 1.33 mmol) in CHCl3/metha-
nol = 2:1 (12 ml) was added 4,40-diformylazobenzene 11 (113 mg,
0.475 mmol) and glacial acetic acid (pH 5). The reaction mixture
was stirred at ambient temperature for 1 h under argon. To the
reaction mixture was added sodium cyanotrihydroborate
(NaBH3CN) (83.5 mg, 1.32 mmol). The reaction mixture was stirred
at room temperature for 2 h. The solvent was concentrated in va-
cuo. The residue was diluted with CHCl3, washed with saturated
aqueous NaHCO3, H2O and brine, and dried over anhydrous MgSO4.
The solvent was concentrated in vacuo and the crude residue was
purified by column chromatography on silica gel (from CHCl3 100%
to CHCl3/methanol = 50:1) to give 17 (306 mg, 0.38 mmol, 80%) as
an orange solid: 1H NMR (400 MHz, CDCl3) d 1.04 (s, 18H), 2.78 (t,
4H, J = 5.1 Hz), 3.81 (t, 4H, J = 5.1 Hz), 3.88 (s, 4H), 7.34–7.46 (16H),
7.61–7.66 (8H), 7.87 (d, 4H, J = 8.3 Hz); 13C NMR (150 MHz, CDCl3)
d 19.3, 27.0, 50.9, 53.2, 63.1, 123.0, 127.8, 128.8, 129.8, 133.6,
135.6, 143.5, 151.9; HRMS (ESI) calcd for C50H61N4O2Si2 [(M+H)+]
805.4333, found 805.4326.
4.1.2. N-(7-Methyl-1,8-naphthyridin-2-yl)carbamic acid 4-
aminobutyl ester (9b)
To a solution of 8 (500 mg, 1.34 mmol) in CHCl3 (10 mL) was
added ethyl acetate (1.67 mL) containing 4 M HCl and the reaction
mixture was stirred at ambient temperature for 1 h. To the reaction
mixture was added additional ethyl acetate containing 4 M HCl
(1.00 mL). After 30 min stirring, solvent was removed in vacuo
and the residue was washed with CHCl3, diluted with saturated
aqueous NaHCO3 solution and extracted with CHCl3. The organic
phase was washed with brine, dried over anhydrous MgSO4, fil-
tered, and concentrated in vacuo to give 9b (292 mg, 1.07 mmol,
80%) as a pale yellow solid: 1H NMR (400 MHz, CDCl3) d = 1.52
(m, 2H), 1.72 (m, 2H), 2.69 (s, 3H), 2.72 (t, 2H, J = 7.1 Hz), 4.18 (t,
2H, J = 6.6 Hz), 7.20 (d, 1H, J = 8.0 Hz), 7.93 (d, 1H, J = 8.0 Hz),
8.05 (d, 1H, J = 8.8 Hz), 8.19 (d, 1H, J = 8.8 Hz); 13C NMR
(150 MHz, CDCl3) d = 25.59, 26.22, 29.69, 41.62, 65.66, 112.67,
117.94, 121.28, 136.40, 138.91, 153.32, 153.50, 154.69, 163.15;
ESI-MS, m/e 297 ([M+Na]+), 571 ([2M+Na]+); HRMS (FAB): calcd
for C14H19O2N4 ([M+H]+) 275.1508, found 275.1508.
4.1.6. N,N0-Bis(tert-butoxycarbonyl)-N,N0-bis[2-(tert-
butyldiphenylsilyloxy)ethyl]-4,40-aminomethylazobenzene (18)
To a solution of 17 (276 mg, 0.34 mmol) in CHCl3 (10 mL) was
added di-tert-butyl dicarbonate (224 mg, 1.03 mmol). The reaction
mixture was stirred at ambient temperature for 3 h under argon
and concentrated in vacuo. The residue was extracted with ethyl
acetate. The organic phase was washed with saturated aqueous
NaHCO3, H2O and brine, and dried over anhydrous MgSO4. The or-
ganic phase was concentrated in vacuo and the crude residue was
purified by column chromatography on silica gel (CHCl3/metha-
nol = 200:1) to give 18 (345 mg, 0.343 mmol, quantitative yield)
as an orange oil. The NMR spectra showed the rotameric mixture
due to high rotation barriers caused by the tertiary amide bond
of t-Boc protective group: 1H NMR (400 MHz, CDCl3) (rotameric
mixture) d 1.04 (s, 18H), 1.41 (s, 18H), 3.32–3.44 (4H), 3.71–3.80
(4H), 4.57–4.61 (4H), 7.32–7.43 (16H), 7.60–7.64 (8H), 7.84 (d,
4H, J = 8.0 Hz); 13C NMR (150 MHz, CDCl3) (rotameric mixture) d
19.1, 26.8, 28.3, 48.5, 48.8, 50.8, 51.6, 62.4, 62.5, 79.8, 85.1,
122.9, 127.7, 128.2, 129.7, 133.3, 135.5, 141.7, 142.1, 151.8,
155.5, 155.8; HRMS (ESI) calcd for C60H76N4O6Si2Na [(M+Na)+]
1027.5201, found 1027.5172.
4.1.3. N-(7-Methyl-1,8-naphthyridin-2-yl)carbamic acid [1,2-
diazenediylbis (4,1-phenylenemethyleneimino-4,1-butanediyl)]
ester (4, NCDA4)
To a mixture of 9b (80 mg, 0.292 mmol) and 4,40-formylazoben-
zene 11 (31.6 mg, 0.13 mmol) in CHCl3 (5 mL) and methanol
(2.5 mL) was added acetic acid (19.0 mL, 0.33 mmol) and the reac-
tion mixture was stirred at ambient temperature for 1 h. Sodium
cyanotrihydroborate (NaBH3CN) (16.7 mg, 0.27 mmol) was added
to the reaction mixture. After 2.5 h stirring, solvent was removed
in vacuo and the residue was diluted with saturated aqueous NaH-
CO3 solution and extracted with CHCl3. The organic phase was
washed with brine, dried over anhydrous MgSO4, filtered, and con-
centrated in vacuo. The crude product was purified by column
chromatography on silica gel (CHCl3/methanol = 20:1) to give 4
(49.5 mg, 0.066 mmol, 50%) as an orange solid: 1H NMR
(400 MHz, CDCl3) d = 1.60 (m, 4H), 1.73 (m, 4H), 2.65–2.68 (10H),
3.83 (s, 4H), 4.18 (t, 4H, J = 6.5 Hz), 7.14 (d, 2H, J = 8.3 Hz), 7.40
(d, 4H, J = 8.1 Hz), 7.63 (br, 2H), 7.80 (d, 4H, J = 8.1 Hz), 7.92 (d,
2H, J = 8.3 Hz), 8.04 (d, 2H, J = 8.8 Hz), 8.19 (d, 2H, J = 8.8 Hz); 13C
NMR (150 MHz, CDCl3) d = 25.95, 26.70, 26.98, 49.17, 53.92,
66.05, 112.93, 118.30, 121.64, 123.24, 129.05, 136.73, 139.29,
143.77, 152.11, 153.55, 153.69, 155.04, 163.54; ESI-MS, m/e 777
([M+Na]+); HRMS (FAB): calcd for C42H47O4N10 ([M+H]+)
755.3782, found 755.3772.
4.1.7. N,N0-Bis(tert-butoxycarbonyl)-N,N0-bis(2-hydroxyethyl)-
4,40-aminomethylazobenzene (19)
To a solution of 18 (368 mg, 0.37 mmol) in THF (7.5 mL) was
added TBAF (1 M in THF) (1.6 mL, 5.6 mmol) and acetic acid (50 lL,
0.87 mmol) and the mixture was stirred at ambient temperature
for 12 h. To the reaction mixture was added additional TBAF
(0.2 mL, 0.70 mmol) at ambient temperature. Then the solvent was
concentrated in vacuo and the crude product was extracted with
ethylacetate. Theorganicphasewaswashedwithsaturatedaqueous
NaHCO3, H2O and brine, and dried over anhydrous MgSO4. The sol-
vent was concentrated in vacuo and the crude residue was purified
by column chromatography on silica gel (CHCl3/methanol = 30:1)
to give 19 (190 mg, 0.359 mmol, 98%) as an orange oil. The NMR
spectra showed the rotameric mixture due to high rotation barriers
4.1.4. 2-(tert-Butyldiphenylsilyloxy)ethylmine (16)
To a solution of 2-aminoethanol 15 (1.06 g, 17.3 mmol) in dry
DMF (20 ml) was added t-butylchlorodiphenyl silane (4.58 g,
17.3 mmol) and imidazole (1.18 g, 17.4 mmol). The reaction mix-
ture was stirred at ambient temperature for 3 h. Then the solvent
was concentrated in vacuo. The residue was diluted with CHCl3,
washed with saturated aqueous NaHCO3, H2O and brine, and dried